Prelude therapeutics to participate in jefferies healthcare conference

Wilmington, del., may 31, 2023 (globe newswire) -- prelude therapeutics incorporated (prelude) (nasdaq: prld), a clinical-stage precision oncology company, announced today that the company will participate in the jefferies healthcare conference, taking place in new york city, june 7 to 9, 2023.
PRLD Ratings Summary
PRLD Quant Ranking